739349
Last Update Posted: 2016-06-06
Recruiting has ended
All Genders accepted | 18 Years + |
132 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
NOVA22007 0.05% and 0.1% Cyclosporine Versus Vehicle for the Treatment of Dry Eye
Study is to assess the safety and efficacy of NOVA22007 0.05% and 0.1% Cyclosporine Ophthalmic Cationic Emulsions QD compared to vehicle for the treatment of the signs and symptoms of dry eye after a 3 month treatment period.
Eligibility
Relevant conditions:
Dry Eye
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov